Phase 1/2Completed
Clinical Study of Umbilical Cord Mesenchymal Stem Cells Infusion for Aging Frailty
A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Study of Umbilical Cord Mesenchymal Stem Cells Infusion for Aging Frailty
- Sponsor
- Shanghai East Hospital (Academic or other)
- Enrolment
- 30 enrolled
- Conditions
- Aging Frailty
- Interventions
- Human umbilical cord mesenchymal stem cells（HUC-MSCs）; Placebo
- Ages
- adults, older adults
- Registry
- NCT04314011
From the registry
The purpose of this clinical study is to answer the questions: 1. Is the proposed intervention safe? 2. Is the proposed intervention effective in improving the healthy status of subjects with aging frailty?
Primary outcomes
- Safety of HUC-MSCs infusion